scPharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 15, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 332.28% from the current stock price of 3.47.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$15	$18	$18
Change	+245.82%	+332.28%	+418.73%	+418.73%

Analyst Ratings

The average analyst rating for SCPH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $18	Strong Buy	Reiterates	$18	+418.73%	Nov 14, 2024
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Strong Buy Maintains $16 → $12	Strong Buy	Maintains	$16 → $12	+245.82%	Nov 14, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $18	Strong Buy	Reiterates	$18	+418.73%	Aug 19, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $18	Strong Buy	Reiterates	$18	+418.73%	May 15, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $18	Strong Buy	Reiterates	$18	+418.73%	Mar 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

40.18M

from 13.59M

195.62%

from 13.59M

Revenue Next Year

98.48M

from 40.18M

145.07%

from 40.18M

EPS This Year

-1.38

from -1.42

EPS Next Year

-0.74

from -1.38

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	13.59M	40.18M	98.48M	189.66M
Revenue Growth	-	-	-	-	-	195.62%	145.07%	92.59%
EPS	-1.77	-1.31	-1.02	-1.30	-1.42	-1.38	-0.74	0.55
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	6.25
No. Analysts	-	-	-	-	-	8	8	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	44.8M	133.3M	259.0M
Avg	40.2M	98.5M	189.7M
Low	36.7M	80.9M	158.1M

Revenue Growth

Revenue Growth	2024	2025	2026
High	229.8%	231.6%	163.0%
Avg	195.6%	145.1%	92.6%
Low	169.6%	101.2%	60.6%

EPS Forecast

EPS	2024	2025	2026
High	-1.35	-0.44	1.27
Avg	-1.38	-0.74	0.55
Low	-1.44	-1.08	0.01

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.